Brief: EMA's CHMP Recommends Extension Of Therapeutic Indication For Pandemic Influenza Vaccine H5N1 AstraZeneca
16/10/2026 11:12
BRIEF-EMA's CHMP Recommends Extension Of Therapeutic Indication For Pandemic Influenza Vaccine H5N1 AstraZeneca Oct 16 (Reuters) - EMA's CHMP:
EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA
EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR KYINSU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novo Nordisk A/S
See all newsFocus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Factbox: Anthropic's public benefit fund and how it compares with other big philanthropic efforts
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Factbox: Major drugmakers turn to China for licensing deals